ArticlemedRxiv : the preprint server for health sciences2026
Presurgical immune biomarkers associated with pain intensity and pain interference recovery after total knee arthroplasty: findings from the PRIME-KNEE study.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Chronic postsurgical pain (CPSP) prevalence after total knee arthroplasty (TKA) is >20%. Circulating immune biomarkers are associated with musculoskeletal pain but poorly understood as CPSP predictors. This prospective, longitudinal study of 203 patients undergoing TKA tested presurgical plasma biomarkers associated with 6-month CPSP, using approaches from geriatrics biomarker research: expected recovery differential (ERD; resilience outcome) and penalized, machine-learning regularization modeling (elastic net and LASSO regression). Forty-nine presurgical candidate biomarkers were considered. CPSP was operationalized using ERDs built around PROMIS pain intensity and pain interference, which quantified the difference between observed and expected recovery after accounting for demographic, comorbidity, reserve, and perioperative factors. Plasma/ERDs from ~130 patients revealed 13 biomarkers with the highest selection stability criteria, and either positive or negative (+/-) associations with ERDs. Interleukin (IL) -5 (-) and Lipopolysaccharide-Binding Protein (LBP; +) were associated with both ERDs. Unique associations with pain intensity ERD included Cytomegalovirus-Specific IgG Negative (CMV IgG-; -), Macrophage Inflammatory Protein-1 Beta (MIP-1β; -), IL-12p70 (-), Cluster of Differentiation 30 (sCD30; -), Interferon alpha 2a (IFNα2a; +), and Leukemia Inhibitory Factor (LIF; +). Unique associations with pain interference ERD included Lipopolysaccharide (LPS; -), Activin A (-), IL-8 (-), Serum Amyloid A (SAA; -), and IL-7 (+). Protein-protein interaction and topological analyses suggest a centralized subnetwork with higher-than-expected connectivity involving IL-5, IL-7, IL-8, MIP-1β, and IFNα-2a, among others. This study proposes rigorous yet feasible approaches to expedite pain biomarker research and introduces presurgical biomarkers to consider in future TKA-CPSP biosignature derivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.